Severe pembrolizumab-associated neutropenia after CD34+ selected allogeneic hematopoietic-cell transplantation for multiple myeloma. Article uri icon

Overview

publication date

  • March 7, 2018

Research

keywords

  • Antibodies, Monoclonal, Humanized
  • Antigens, CD34
  • Antineoplastic Agents, Immunological
  • Hematopoietic Stem Cell Transplantation
  • Multiple Myeloma
  • Neutropenia
  • Transplantation, Autologous
  • Transplantation, Homologous

Identity

PubMed Central ID

  • PMC6984164

Scopus Document Identifier

  • 85042915936

Digital Object Identifier (DOI)

  • 10.1038/s41409-018-0142-4

PubMed ID

  • 29515248

Additional Document Info

volume

  • 53

issue

  • 8